T. Rowe Price U.S. Equity Research Fund

The investment seeks long-term capital growth. The fund uses a disciplined portfolio construction process whereby it weights each sector and industry approximately the same as the Standard & Poor's 500 Stock Index® (S&P 500 Index). While the majority of assets will be invested in large-capitalization U.S. common stocks, the fund may have small- and mid-capitalization and foreign exposure in keeping with fund objectives.

T. Rowe Price U.S. Equity Research Fund trades as PRCOX on NASDAQ. The company is classified in Financial Services / Asset Management and reports in USD.

The current profile places the business in Asset Management. This section is intended to summarize the operating segments, products, geographies, and main revenue lines from official filings.

Detailed operating-segment data is not available for this symbol yet.

Use this area for management strategy, capital allocation priorities, target markets, and measurable goals from the latest annual report or investor presentation.

The app now provides the structure, but exact strategic claims should come from official company documents before being treated as a finished investment thesis.

T. Rowe Price U.S. Equity Research Fund can be compared against peers such as American Century Emerging Markets Fund, Congress Small Cap Growth Fund, Eaton Vance Tax-Managed Buy-Write Opportunities Fund, FAM Value Fund, Nationwide S&P 500 Index Fund, Columbia Cornerstone Equity Fund Class A.

A complete thesis should compare growth, margins, balance-sheet risk, valuation multiples, and market position against direct competitors.

Current signals to investigate include market capitalization of $1.85B, beta of 1.01, and return on equity of N/A.

This section should be validated with evidence such as durable margins, brand strength, regulation, switching costs, cost advantage, distribution, or technology.

Key risks should include financial leverage, cyclicality, customer concentration, regulatory exposure, currency risk, and execution risk.

PRCOX currently shows total debt of N/A and beta of 1.01. Missing data should be treated as a research gap, not as low risk.

Production-capacity detail is not available as structured data yet. For industrial, defense, semiconductor, or real-estate companies, this should be reviewed from annual reports and investor presentations.

No structured backlog field is available yet. If the company reports backlog, review the relevant filing section before adding it to the thesis.

Use this section for major contracts, product launches, construction projects, acquisitions, or strategic programs that can materially affect valuation.

Recent filings to review: NPORT-P (2026-05-28 00:00:00), DEFA14A (2026-05-26 00:00:00), 497 (2026-05-01 00:00:00), DEF 14A (2026-04-02 00:00:00).

Customer concentration is not available as structured data here. Add it from official filings when a company discloses material customers or revenue concentration.

Supplier concentration and critical supply-chain dependencies are not available as structured data here. This should be researched from annual reports and risk disclosures.

Company website: https://www.troweprice.com/financial-intermediary/us/en/investments/mutual-funds/us-products/us-equity-research-fund.html

For US-listed stocks, verify the thesis against official filings, earnings call transcripts, and company investor relations materials.